| Middle East respiratory syndrome (MERS) |
|
|---|---|
| Other names | Camel flu |
 |
|
| MERS-CoV virions | |
| Specialty | Infectious disease |
| Symptoms | Fever, cough, shortness of breath[1] |
| Usual onset | 2 to 14 days post exposure[2] |
| Duration | 2012–2020[3] |
| Causes | MERS-coronavirus (MERS-CoV)[1] |
| Risk factors | Contact with camels and camel products[1] |
| Diagnostic method | rRT-PCR testing[4] |
| Prevention | Hand washing, avoiding contact with camels and camel products[5] |
| Treatment | Symptomatic and supportive[1] |
| Prognosis | 34.4% risk of death (all countries) |
| Frequency | 2578 cases (as of October 2021)[3] |
| Deaths | 888[3] |
| Middle East respiratory syndrome (MERS) |
|
|---|---|
| Other names | Camel flu |
|
|
| MERS-CoV virions | |
| Specialty | Infectious disease |
| Symptoms | Fever, cough, shortness of breath[1] |
| Usual onset | 2 to 14 days post exposure[2] |
| Duration | 2012–2020[3] |
| Causes | MERS-coronavirus (MERS-CoV)[1] |
| Risk factors | Contact with camels and camel products[1] |
| Diagnostic method | rRT-PCR testing[4] |
| Prevention | Hand washing, avoiding contact with camels and camel products[5] |
| Treatment | Symptomatic and supportive[1] |
| Prognosis | 34.4% risk of death (all countries) |
| Frequency | 2578 cases (as of October 2021)[3] |
| Deaths | 888[3] |
